Categories: Research

Michael Marletta, PhD, who completed his PhD in pharmaceutical chemistry at UCSF in 1977, was elected to the National Academy of Sciences on April 25, 2006 at the Academy's 143rd annual meeting in Washington, DC. While a PhD graduate student at UCSF, Marletta worked under research advisor George...

Using standards that measure a university's openness and diversity, as well as distinction in research, Newsweek International ranked UCSF 9th among the top 100 global universities as reported in the publication's August 13, 2006 online issue.

Pamela M. England, PhD, UCSF School of Pharmacy faculty member and expert in the areas of neuroscience and memory formation, will receive one of four Technological Innovations in Neuroscience Awards for 2006-2008. The award is from The McKnight Endowment Fund for Neuroscience.

Christopher A. Voigt, PhD, UCSF School of Pharmacy scientist, and colleagues are engineering bacteria to target tumors and create images. This work is part of the emerging field of synthetic biology, which aims to create new biological parts, systems, and tools, and redesign existing biological...

Three UCSF School of Pharmacy scientists, Paul R. Ortiz de Montellano, PhD; Christopher A. Voigt, PhD; and James A. Wells, PhD have been recognized for their outstanding research.

Through better understanding of where and how the brain gets, or "traffics," fresh supplies of particular receptors needed to carry chemical signals between nerve cells, researchers hope to better understand how we learn, remember, and possibly forget.

For the 2nd consecutive year, UCSF topped all United States universities and colleges in both total and federally financed spending for chemistry research and development. These results reflect data for 2003 from the National Science Foundation. These are the most recent statistics available as of...

By genetically engineering microbes to act like biological camera film, UCSF School of Pharmacy assistant professor Christopher A. Voigt, PhD and doctoral students show the potential of the new field of synthetic biology to create useful tools for medicine and technology. Details of this research...

Robert Langridge, PhD, professor emeritus of the School of Pharmacy, University of California, San Francisco, is highlighted as one of 35 innovators of our time by the editors of Smithsonian Magazine in its November 5, 2005 issue.

James Wells, PhD, a leader in the development of new technologies to aid drug discovery and protein engineering, joins UCSF as the first holder of the Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences. Wells will hold joint faculty appointments in the Schools of...